Sensient director awarded deferred stock grant
Sensient Technologies director Joseph Carleone received 422.547 shares of deferred stock as a grant tied to director fee deferrals.
Rhea-AI Filing Summary
Sensient Technologies director Joseph Carleone received 422.547 shares of deferred stock as a grant tied to director fee deferrals. This deferred stock converts into common stock on a one-for-one basis and is issued after his service as a director ends.
Following the grant, his reported deferred stock holdings total 23,780.400 shares. A separate holding entry shows 22,551.313 shares of common stock held directly, which includes restricted stock under the company’s 2017 Stock Plan and shares accumulated through a dividend reinvestment plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock | 422.547 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
- F2. Deferred stock converts to common stock on a one-for-one basis.
- F3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
- F4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
Key Figures
Key Terms
Deferred Stock financial
Directors' Deferred Compensation Plan financial
dividend reinvestment plan financial
restricted stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Sensient Technologies (SXT) director Joseph Carleone report in this Form 4?
How and when does the deferred stock reported by Sensient (SXT) convert into common stock?
What does the Form 4 say about Joseph Carleone’s direct common stock holdings in Sensient (SXT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.